Cargando…
LRP6 targeting suppresses gastric tumorigenesis via P14(ARF)–Mdm2–P53-dependent cellular senescence
NLRP6, a member of the Nod-like receptor family, protects against chemically induced intestinal injury and colitis-associated colon cancer. However, the cellular mechanisms involved in this NLRP6-mediated protection remain unclear. Here, we show that NLRP6 was down-regulated in approximately 75% of...
Autores principales: | Wang, Haibin, Xu, Guoxing, Huang, Zhengjie, Li, Weizheng, Cai, Huali, Zhang, Yunda, Xiong, Disheng, Liu, Gang, Wang, Shengjie, Xue, Zengfu, Luo, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762345/ https://www.ncbi.nlm.nih.gov/pubmed/29340077 http://dx.doi.org/10.18632/oncotarget.22876 |
Ejemplares similares
-
Correction: NLRP6 targeting suppresses gastric tumorigenesis via P14(ARF)–Mdm2–P53-dependent cellular senescence
por: Wang, Haibin, et al.
Publicado: (2018) -
Pinning Control for the p53-Mdm2 Network Dynamics Regulated by p14ARF
por: Suarez, Oscar J., et al.
Publicado: (2020) -
It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
por: Kung, Che-Pei, et al.
Publicado: (2022) -
Overexpression of CCDC69 activates p14(ARF)/MDM2/p53 pathway and confers cisplatin sensitivity
por: Cui, Long, et al.
Publicado: (2019) -
The RP-Mdm2-p53 Pathway and Tumorigenesis
por: Miliani de Marval, Paula L., et al.
Publicado: (2011)